Dsk

DSK is a KOSDAQ-listed company that grew on display equipment and mechatronics-based precision systems before expanding into secondary battery manufacturing equipment.

Its main product lines are FPD Bonding/In-line Systems, secondary battery electrode, assembly and activation process equipment, and camera module equipment.

Because battery equipment must be tailored to each manufacturer's process, the company treats partnerships with LG Energy Solution, Samsung SDI and SK On as a core competitive asset.

It historically grew by supplying equipment to large display makers such as LG Display and BOE, and has more recently reportedly won assembly-process equipment orders from HL-GA Battery Company LLC, the Hyundai Motor-GM joint venture.

Its manufacturing-equipment supply business carries a high export share, leaving it fairly dependent on overseas sales. Beyond its core businesses, the company is expanding into factory automation (FA), bio, and renewable energy to develop future growth drivers.

FPD Bonding/In-line Systems form an oligopolistic market because only Japanese firms and a small number of domestic players hold the production technology for these high-performance systems, with two to three companies competing in each process.

The Synergy Innovation group, its former controlling shareholder group, also includes bio affiliates such as botulinum toxin maker Protox and drug developer NeuroBiogen, creating an ownership-level link to the bio business as well.

Annual revenue rose from KRW 48.23 billion in 2022 to KRW 71.50 billion in 2023, then plunged to KRW 22.64 billion in 2024 before rebounding to KRW 43.18 billion in 2025.

Operating profit remained negative for four straight years, at -KRW 13.12 billion (2022), -KRW 9.71 billion (2023), -KRW 19.70 billion (2024) and -KRW 22.72 billion (2025). The operating margin narrowed to -13.6% in 2023 before deteriorating sharply to -87.0% in 2024 and partially recovering to -52.6% in 2025.

Net income attributable to owners was positive only in 2023, at KRW 3.26 billion, while 2022 (-KRW 6.45 billion), 2024 (-KRW 7.84 billion) and 2025 (-KRW 15.52 billion) were all losses, with 2025 the deepest.

On a quarterly basis, 2Q25 revenue jumped unusually to KRW 30.86 billion, only for 3Q25 (KRW 4.81 billion) and 4Q25 (KRW 4.41 billion) revenue to fall sharply while operating losses widened to -KRW 8.45 billion and -KRW 5.40 billion respectively, underscoring the high quarter-to-quarter volatility in results.

In 2026, 1Q revenue was KRW 4.90 billion with an operating loss of -KRW 5.72 billion, and 2Q revenue rose to KRW 6.43 billion with the operating loss narrowing to -KRW 3.06 billion, alongside a narrowing net loss attributable to owners from -KRW 2.38 billion to -KRW 1.48 billion.

Still, the cumulative net loss attributable to owners over the trailing four quarters (3Q25 through 2Q26) reached KRW 13.31 billion, indicating the earnings recovery remains incomplete.

Owners' equity also declined for three straight years, from KRW 132.31 billion in 2023 to KRW 120.22 billion in 2024 and KRW 105.22 billion in 2025, reflecting how accumulated losses have been eroding capital.

The secondary battery manufacturing equipment market is classified as a growth industry, projected to expand from roughly $17.5 billion in 2024 to $50.5 billion by 2030 at about a 14% annual growth rate.

However, demand softness and uncertainty are reportedly increasing at the same time, driven by changes to US IRA policy, subsidy cuts in Europe and China, and the EV market entering a maturing phase.

The FPD Bonding/In-line System market is a high-barrier oligopoly in which only Japanese firms and a handful of domestic players hold production technology, with two to three companies competing in each process.

DSK is one of the few listed companies active in both industries, exposing it simultaneously to a display-sector recovery and to the timing of renewed capacity investment by battery cell makers.

Several listed domestic companies compete in battery assembly and lamination-process equipment, a segment where order flow to individual suppliers can vary widely depending on large cell makers' capacity investment decisions.

Given the company's high export exposure, its results are also tied to currency movements and the timing of overseas customers' investment decisions.

In August 2025, controlling shareholder Synergy Innovation and affiliates signed a deal to sell their controlling stake to a Yoonjin Partners-led consortium for KRW 81.596 billion, a transaction assessed as effectively not including a control premium.

The deal reportedly included preconditions such as the appointment of buyer-nominated directors and completion of regulatory product approval for an affiliated bio subsidiary.

However, as of March 17, 2026 the deal faced termination risk due to the buyer's non-payment, before an additional agreement on March 31 rescheduled an extra deposit of KRW 5 billion (due April 30) and a balance of KRW 69.896 billion (due June 15), while extending the final closing deadline (long-stop date) to June 30.

Korea Exchange disclosure records show a 'change of controlling shareholder' filing on May 27, 2026 and a further corrective filing related to the agreement on July 23, 2026, suggesting the ownership transfer process has gone through repeated adjustments while nearing completion.

On the business side, the company has reportedly won assembly-process equipment orders from core customers LG Energy Solution and HL-GA Battery Company LLC, with industry estimates putting the related order value at more than KRW 100 billion.

Alongside this battery-equipment order base tied to large customers, the company continues to pursue business diversification into FA, bio, and renewable energy.

Because equipment-sector revenue recognition tends to be uneven across quarters, the pace and extent to which order wins translate into actual earnings improvement will need to be confirmed through upcoming quarterly disclosures.